HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Gert Jan Lammers Selected Research

Sleep Wake Disorders

1/2022Reduced Numbers of Corticotropin-Releasing Hormone Neurons in Narcolepsy Type 1.
1/2021The orexin/hypocretin system in neuropsychiatric disorders: Relation to signs and symptoms.
11/2018Enhanced food-related responses in the ventral medial prefrontal cortex in narcolepsy type 1.
5/2016Pandemic influenza vaccine & narcolepsy: simulations on the potential impact of bias.
12/2012Association between hypocretin-1 and amyloid-β42 cerebrospinal fluid levels in Alzheimer's disease and healthy controls.
8/2012Hypocretin (orexin) loss in Alzheimer's disease.
4/2012Altered circadian rhythm of melatonin concentrations in hypocretin-deficient men.
2/2009Hypocretin/orexin disturbances in neurological disorders.
5/2005Altered setting of the pituitary-thyroid ensemble in hypocretin-deficient narcoleptic men.
4/2003Screening for anti-ganglioside antibodies in hypocretin-deficient human narcolepsy.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Gert Jan Lammers Research Topics

Disease

53Narcolepsy
12/2022 - 10/2002
21Cataplexy
12/2022 - 10/2002
13Sleep Wake Disorders
01/2022 - 10/2002
9Disorders of Excessive Somnolence (Hypersomnia)
12/2022 - 10/2002
6Obesity
11/2016 - 09/2003
3Nervous System Diseases (Neurological Disorders)
01/2021 - 10/2002
3Parkinson Disease (Parkinson's Disease)
01/2008 - 10/2002
2Obstructive Sleep Apnea
01/2020 - 10/2002
2Human Influenza (Influenza)
10/2018 - 05/2016
2Body Weight (Weight, Body)
08/2013 - 03/2003
2Alzheimer Disease (Alzheimer's Disease)
12/2012 - 08/2012
2Prader-Willi Syndrome (Syndrome, Prader-Willi)
09/2005 - 10/2002
1Pain (Aches)
01/2021
1Weight Gain
01/2019
1Brain Diseases (Brain Disorder)
01/2019
1Opioid-Related Disorders (Opiate Addiction)
01/2018
1Insulin Resistance
04/2014
1Weight Loss (Weight Reduction)
04/2014
1Abdominal Pain (Pain, Abdominal)
11/2013
1Substance Withdrawal Syndrome (Withdrawal Symptoms)
11/2013
1Dementia (Dementias)
08/2012
1Substance-Related Disorders (Drug Abuse)
06/2011
1Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease)
10/2009
1Neurodegenerative Diseases (Neurodegenerative Disease)
10/2009
1Stroke (Strokes)
10/2006
1Abdominal Obesity
09/2003
1Guillain-Barre Syndrome
04/2003
1Breast Neoplasms (Breast Cancer)
12/2002
1Opsoclonus-Myoclonus Syndrome (Kinsbourne Syndrome)
12/2002
1Adenocarcinoma
12/2002
1Restless Legs Syndrome (Restless Legs)
10/2002
1Sleep Initiation and Maintenance Disorders (Insomnia)
10/2002
1Type C Niemann-Pick Disease (Niemann Pick Disease, Type C)
10/2002

Drug/Important Bio-Agent (IBA)

41OrexinsIBA
12/2022 - 10/2002
9Sodium Oxybate (gamma Hydroxybutyrate)FDA Link
01/2019 - 01/2010
3solriamfetolIBA
11/2022 - 01/2020
3Dopamine (Intropin)FDA LinkGeneric
11/2022 - 01/2020
3Norepinephrine (Noradrenaline)FDA LinkGeneric
11/2022 - 01/2020
3Biomarkers (Surrogate Marker)IBA
01/2022 - 06/2014
3VaccinesIBA
10/2018 - 02/2013
2Pharmaceutical PreparationsIBA
01/2022 - 01/2019
2HLA-DQB1 antigen (HLA DQB1)IBA
12/2021 - 10/2002
2Modafinil (Provigil)FDA Link
01/2019 - 11/2013
2pandemrixIBA
10/2018 - 05/2016
2Glucose (Dextrose)FDA LinkGeneric
04/2014 - 10/2013
2Growth Hormone (Somatotropin)IBA
06/2011 - 03/2003
1Corticotropin-Releasing HormoneIBA
01/2022
1Opioid Analgesics (Opioids)IBA
01/2019
1NeuropeptidesIBA
11/2018
1SteroidsIBA
09/2018
1Natalizumab (Tysabri)FDA Link
09/2018
1Immunoglobulins (Immunoglobulin)IBA
09/2018
1Opiate AlkaloidsIBA
01/2018
1Morphine (MS Contin)FDA LinkGeneric
01/2018
1Influenza Vaccines (Influenza Vaccine)FDA Link
05/2016
1Glycerol (Glycerine)FDA LinkGeneric
04/2014
1Insulin (Novolin)FDA Link
04/2014
1Amphetamine (Amfetamine)FDA LinkGeneric
11/2013
1Histamine H3 Receptors (Histamine H3 Receptor)IBA
11/2013
1pitolisantIBA
11/2013
1LeptinIBA
08/2013
1Hormones (Hormone)IBA
08/2013
1GhrelinIBA
08/2013
1OX40 LigandIBA
01/2013
1Cathepsin HIBA
01/2013
1T-Cell Antigen Receptors (T-Cell Receptor)IBA
01/2013
1Neurotransmitter Agents (Neurotransmitter)IBA
08/2012
1MelatoninIBA
04/2012
1N 30IBA
06/2011
1ProlactinIBA
03/2011
1Adrenocorticotropic Hormone (ACTH)FDA Link
03/2011
1Intravenous Immunoglobulins (IVIG)FDA Link
11/2007
1AutoantibodiesIBA
05/2006
1AntigensIBA
04/2003
1GangliosidesIBA
04/2003
1AntibodiesIBA
04/2003
1ANNA-2 antibodyIBA
12/2002
1Psychotropic Drugs (Psychoactive Drugs)IBA
10/2002
1Biological ProductsIBA
10/2002
1HLA-DQ Antigens (HLA-DQ)IBA
10/2002

Therapy/Procedure

1Aftercare (After-Treatment)
04/2014
1Cesarean Section (Caesarean Section)
10/2013
1Institutionalization (Institutionalized Persons)
08/2012
1Contraindications
10/2006
1Therapeutics
10/2003